SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for patients ...
Fintel reports that on December 16, 2024, Exane BNP Paribas upgraded their outlook for Equifax (NYSE:EFX) from Neutral to Outperform. As of December 3, 2024, the average one-year price target for ...
It has been about a month since the last earnings report for Equifax (EFX). Shares have lost about 16.5% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading ...
EQUIFAX insiders have traded $EFX stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales. Here’s a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results